SDOH in Cancer Podcasts

		Dr. Reggie Tucker-Seeley and Erica Warner discuss potential barriers to integrating social care into cancer care delivery.
		Dr. Reggie Tucker-Seeley and Dr. Narjust Florez discuss the importance of cultural humility in cancer care and how that impacts/influences the social determinants of health as patients navigate the healthcare delivery system.
		Dr. Reggie Tucker-Seeley and Dr. Karen Winkfield discuss advocacy and healthcare delivery system issues in addressing SDOH in cancer care.
		Dr. Reggie Tucker-Seeley and Dr. Evan Graboyes discuss the challenge in navigating current payment issues when addressing social needs, including z-codes and whey they are underutilized in healthcare/cancer care.

CLICK HERE to go to the SDOH in Cancer Web Sympoisum Homepage

About the Program:

• Target Audience
• Learning Objectives
• Faculty
• Joint Accreditation Statement
• Credit Designations
• Disclosure of Conflicts of Interest
• Instructions for Credit
• Disclosure of Unlabeled Use
• Disclaimer
• Computer System Requirements

Target Audience:

This activity is designed to meet the educational needs of case managers, nurses, pharmacists, pharmacy technicians, physicians, psychologists, social workers, dietitians, and other health care professionals who are interested in learning about the impact of social determinants of health in cancer care.

Learning Objectives:

Release Date: April 12, 2024

Expiration Date: April 12, 2025

Estimated time to complete the activity: 2 hours (30 minutes/podcast)

Back to Top

Faculty:

	Reginald Tucker-Seeley, ScD, ScM, MA - (Course Director) Principal/Owner, Consultant Health Equity Strategies and Solutions Los Angeles, California
	Narjust Florez, MD Associate Director, The Cancer Care Equity Program Thoracic Oncologist, Lowe Center for Thoracic Oncology Dana-Farber Cancer Institute Member of the Faculty Harvard Medical School Boston, Massachusetts
	Evan Graboyes, MD Associate Professor Departments of Otolaryngology-Head & Neck Surgury and Pubilc Health Sciences Medical University of South Carolina Director  Survivorship and Cancer Outcomes Research (SCOR) Hollings Cancer Center  Vice Chair NRG Ongology Health Disparities Committee Charleston, South Carolinga
	Erica T. Warner, ScD, MPH Assistant Professor of Medicine Massachusetts General Hospital Harvard Medical School Boston, Massachusetts
	Karen M. Winkfield, MD, PhD Professor of Radiation Oncology Vanderbilt University Medical Center; Ingram Professor of Cancer Research Vanderbilt Ingram Cancer Center; Professor of Medicine Meharry Medical College; Executive Director Meharry-Vanderbilt Alliance Nashville, Tennessee

Back to Top

Joint Accreditation Statement:

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and ViralEd, Inc. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Back to Top

Physician Continuing Education:

PACE designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Develpment:

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 2.0 contact hours.

Pharmacy Continuing Education:

PACE designates this continuing medical education activity for 2.0 contact hour(s)(0.2 CEUs) of the Accreditation Council for Pharmacy Education.

Type of Activity: Knowledge

PA Continuing Medical Education:

PACE has been authorisezed by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.0 AAPA Category 1 CME credits.  Approval is valid until April 12, 2025.  PAs should only claim credit commensurate with the extent of their particpation.

Drs. Erica Warner and Reginald Tucker-Seeley: 0.5 AMA PRA Category 1 Credits^TM, 0.5 AAPA credit, 0.5 ANCC and ACPE contact hours.
UAN: JA4008073-999-24-087-H01-P

Drs. Narjust Florez and Reginald Tucker-Seeley: 0.5 AMA PRA Category 1 Credits^TM, 0.5 AAPA credit, 0.5 ANCC and ACPE contact hours.
UAN: JA4008073-999-24-089-H01-P 

Drs. Karen Winkfield and Reginald Tucker-Seeley: 0.5 AMA PRA Category 1 Credits^TM, 0.5 AAPA credit, 0.5 ANCC and ACPE contact hours.
UAN: JA4008073-999-24-088-H01-P

Drs. Evan Graboyes and Reginald Tucker-Seeley: 0.5 AMA PRA Category 1 Credits^TM, 0.5 AAPA credit, 0.5 ANCC and ACPE contact hours.
UAN: JA4008073-999-24-090-H01-P

For Pharmacists: Upon successfully completing the post-test and the activity evalutation form, transcript information will be sent to the NABP CPE Monitor Serv ice within 4-6 weeks.

Back to Top

Disclosure of Conflicts of Interest:

PACE requires every individual in a position to control educational content  to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling or distributing healthcare products by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to PACE policies. Others involved in the planning of this activity have no financial relationships.

Reginald Tucker-Seeley, ScD, ScM, MA, faculty for this educational activity, has no relevant financial relationships.

Back to Top

Instructions for Credit:

1. There are no fees for participating in and receiving CME credit for this activity.
2. During the period April 12, 2024, through April 12, 2025, participants must read the educational objectives and faculty disclosures and study the educational activity.
3. If you wish to receive acknowledgment for completing this activity, please complete the evaluation, using the link below.
4. Upon registering and completing the activity evaluation, your certificate will be made available immediately.

To Claim Credit for this activity, please go to: https://paceducation.com/SDOHpodcasts

For additional information about the accreditation of this activity, please visit: https://partnersed.com

Back to Top

Disclosure of Unlabeled Use:

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Back to Top

Disclaimer:

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Back to Top

Computer System Requirements:

This program requires HTML 5 enabled web browsers such as; Microsoft Edge, Mozilla Firefox, Apple Safari or Google Chrome.

Back to Top

An Independent CME Activity Jointly Provided by Partners for Advancing Clinical Education and ViralEd, Inc.

This activity is supported by independent educational grants from Merck & Co. Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Regeneron Pharmaceuticals, Inc. and Seagen Inc.